binx health is transforming the delivery of diagnostic testing by bringing high-quality molecular diagnostics directly to the point of care . Based in the United States and rooted in a vision of equitable, accessible healthcare, binx health’s mission is to break down barriers to timely diagnosis and enable immediate treatment decisions.

Their flagship platform, the binx io, is an FDA-cleared, CLIA-waived molecular diagnostic system that delivers chlamydia and gonorrhea results in around 30 minutes. With this rapid, on-site turnaround and streamlined workflow, binx health is enabling clinics, community health centres and other care-settings to shift from “test and wait” to “test and treat” in a single visit.

By combining advanced diagnostics hardware with digital integration and reimbursement-ready pathways, binx health offers a scalable solution to expand access to infectious‐disease testing and streamline clinical workflows.